EFFECT OF LOW-DOSE BETA-BLOCKERS ON ATRIAL AND VENTRICULAR (B-TYPE) NATRIURETIC FACTOR IN HEART-FAILURE - A DOUBLE-BLIND, RANDOMIZED COMPARISON OF METOPROLOL AND A 3RD-GENERATION VASODILATING BETA-BLOCKER
Je. Sanderson et al., EFFECT OF LOW-DOSE BETA-BLOCKERS ON ATRIAL AND VENTRICULAR (B-TYPE) NATRIURETIC FACTOR IN HEART-FAILURE - A DOUBLE-BLIND, RANDOMIZED COMPARISON OF METOPROLOL AND A 3RD-GENERATION VASODILATING BETA-BLOCKER, British Heart Journal, 74(5), 1995, pp. 502-507
Objectives-This study examines the acute effects of two differing beta
adrenergic blocking agents (metoprolol and a third generation vasodil
ating beta blocker) on plasma concentrations of atrial natriuretic fac
tor (ANF), brain (ventricular) natriuretic factor (BNF), and haemodyna
mic variables in patients with heart failure. Setting-University teach
ing hospital. Methods-20 patients with impaired left ventricular systo
lic function [ejection fraction 32 (SEM 2.3)%] were randomised in a do
uble blind manner to receive either oral metoprolol 6.25 mg twice dail
y or celiprolol 25 mg daily. Haemodynamic variables were evaluated by
Swan-Ganz pulmonary artery catheter over 24 hours. ANF and BNF concent
rations were measured at baseline, 5 h, and 24 h by radioimmunoassay.
Results-At baseline ANF and BNF concentrations were considerably raise
d compared to the normal range. Treatment with metoprolol caused ANF t
o rise further to 147% of the basal level at 5 h (P = 0.017) and 112%
at 24 h (P = 0.029). This was associated with a small but non-signific
ant rise in pulmonary capillary wedge pressure. Cardiac output and sys
temic vascular resistance were unchanged at 24 h. In contrast, after c
eliprolol ANF fell to 90% of basal levels at 5 h and to 74% of basal l
evel at 24 h (P = 0.019), associated with a small but non-significant
fall in pulmonary capillary wedge pressure [-3.3 (2.7) mm Hg] and syst
emic vascular resistance, and rise in cardiac output from 3.2 (0.2) to
4.0 (0.4) 1/min (P = 0.04). BNF concentrations rose to 112% of baseli
ne at 5 h (P 0.09) after metoprolol but fell slightly, to 91% of basel
ine values, after celiprolol (NS). Conclusions-Metoprolol, even in ver
y low doses (6.25 mg), produced a rise in ANF and BNF, although minima
l haemodynamic changes were detected. In contrast, a vasodilating beta
blocker was associated with a significant fall in ANF and BNF and a s
mall rise in cardiac output. This study confirms both the advantages o
f vasodilating beta blockers over metoprolol for initial treatment of
heart failure and the usefulness of ANF and BNF measurements for the a
ssessment of drug effects in heart failure compared to traditional hae
modynamic measurements.